Discodermolide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDiscodermolide
Drug Alias NameDisermolide(+)-DiscodermolideNVP-XAA-296XAA-296AXAA-296
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionApoptosis stimulantsTubulin inhibitorsImmunosuppressants
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHarbor
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKosan Biosciences IncorporatedHarborNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia